CKD Flashcards

(31 cards)

1
Q

CKD-EPI equation better for

A

eGFR <60

Not validated in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

eGFR is not appropriate for

A

AKI
Assumes steady state of creatinine generation and excretion. Better for CKD.

Can’t be used in AKI, children, preganncy, extremes of body weight (anorexia, body builders), patients taking creatinine supplements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Staging CKD combines

A

eGFR

Albuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Preferred method of detecting proteinuria for screening in CKD

A

ACR

Easy to do and monitor with time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ACR vs PCR in CKD

A

When ACR is low, relationship is not clear

If ACR 3.5-34mg/ml, prefer ACR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

People with CKD are most likely to die from

A

CV disease (MI + HF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

People with CKD are most likely to die from

A

CV disease (MI + HF)

Mortality risk is generally higher than risk of needing diagnosis/Tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Definition of CKD

A

eGFR <60, structural abnormalities or persistent abnormalities for >3/12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Indications for kidney biopsy

A

AKI not recovering
Nephrotic range proteinuria (GN)
CKD with progressive/rapid loss of function
Acute nephritis - RPGN, acute GN (AKI, blood and protein in urine)

Assess treat response (after treatment for rejection for kidney transplant)
Assess prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

General management of CKD

A

WH nephrotoxics when unwell

Manage BP
Reduce albuminuria 
- ACEi/ARBI
- Spironolactone
- Non-dihydropyridine CCB 
- SGLT2i

Manage complications
HTN
- As the CKD gets worse, requires more and more antihypertensives (add and don’t change)

Fluid overload

  • Primarily sodium restriction
  • Occasionally FR
  • Thiazide +/- loop
Anaemia
Nutritional advice
- Dietary sodium <1500mg/day
- DASH diet can reduce SBP by 11mmHg
Acidosis 
Mineral disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MOA thiazide

A

Works in DCT

Disconnect between water and Na reabsorption = dilutional hyponatraemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

EPO in CKD

Benefits

A

Increase Hb and symptoms
Target Hb 100-120
No reduction in mortality or kidney function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ferritin and TSAT target in CKD when using EPO

A

Serum ferritin 200-500

TSAT 20-30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

If anaemia doesn’t improve with EPO, what to think of?

A

Think of
Fe deficiency
Inflammation/infection

Also
HIgh PTH
B12, folate defiency
Hypothyroid
Marrow disorder
Malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Protein restriction in CKD

Any evidence?

A

Yes
Reduces loss of GFR
But malnutrition and increase mortality so its a fine balance. Need dietician advice.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does hyperPTH cause anaemia?

A

HyperPTH –> change in bone marrow (more bone than marrow; fibrotic change) –> less red cells coming out of BM

17
Q

CKD and acidosis

Pathophysiology
Consequences
Rx

A

Reduced GFR –> H+ retention –> reduced interstitial and intracellular pH –> inflammation – > interstitial fibrosis –> progression of CKD

Dimineralise bone
Reduced albumin synthesis
Chronic inflammation
Increased degradation of muscle

Rx
Diet - increase fruit and veg (metabolised to bicarb)
Sodium bicarbonate (aim >21)
- Risk of alkalosis and sodium loading

Correcting acidosis can slow down loss of function

18
Q

CKD and mineral bone disorder

Pathophysiology
Rx

A

Reduced GFR –> retain phosphate –> PTH goes up –> phosphate comes down via urine loss + increased Ca2+ + decreased 1,25 dihydroxyitamin D

Strong epidemiological association between Ca, phos, PTH and mortality/CVD

Current guidelines suggest “normal” levels should be target
No guidance on how to achieve
No mortality evidence for phosphate binders

19
Q

Do diabetes ESKD cause small or big kidneys?

A

Big

Otherwise most CKD is small kidneys

20
Q

How do NSAIDs cause AKI?

A

Reduce afferent vasodilation

Increase efferent vasoconstriction

21
Q

How do ACEI cause AKI?

A

Vasodilate afferent
Vasodilate efferent
Increase glomerular pressure

22
Q

Effects of SGLT2i in CKD

A

Can initially reduce GFR (due to increasing sodium delivery to macular densa cells –> dilate afferent arteriole which is bad when there is high glomerular pressure)

But later on becomes renoprotective and reduced loss of GFR comperd to placebo

23
Q

What eGFR can you not use SGLTi?

24
Q

What eGFR can you not use ACEI?

A

No hard rule
If GFR is below 15, be very cautious
And expect a reduction in GFR

25
What eGFR can you not use metformin?
Ok until eGFR 30, dose reduce down to eGFR 20
26
Why does HbA1c improve with worsening CKD?
Cause they're not eating | Risk of hypoglycaemia increases with CKD stage
27
Polycystic kidney disease Rx
Tolvaptan and reduce kidney function loss | but side effects often intolerable
28
What eGFR can you not use DPP4i?
eGFR <30
29
What eGFR can you not use GLP1 agonist?
Increased side effects at lower GFR but good for weight loss
30
What eGFR can you not use sulphonylureas?
Can use | Increased risk of hypoglycaemia
31
Haemodialysis vs CRRT
``` Haemodialysis Fast pump speed x3-7/week for 3-5h/session Rapid solute clearance and fluid removal Access via AVF/AVG/catheter Anticoagulation preferred but not Essential Haemodynamic tolerability can be unstable Location anywhere with access to water Drug dosing can be complicated More time off therapy Good for Stable patients, chronic treatments Rapid clearance of K+, H+, fluid ``` ``` CRRT Slow pump speed Continuous until filter clots Slow solute clearance and fluid removal Access via catheter Anticoagulation usually necessary Haemodynamic tolerability usually good Location ICU Drug dosing can be complicated Time off therapy less Good for Unstable patients in ICU ```